In the US, pharmaceutical companies have begun testing a vaccine against coronavirus

American pharmaceutical manufacturer Pfizer and its German partner BioNTech launch the work to test vaccines against coronavirus infection. This post was published 5 may, the press service of CNBC.

The test vaccine is produced on human volunteers, while obtaining good results, by the end of 2020, the vaccine can be ready to use.

According to data by CNBC, for a full range of tests have formed the necessary number of volunteers. The main goals are pursued in this stage is to find out how effective and safe is the new vaccine. Ate its efficacy and safety is proved, to extensive use of pharmacists will move to the end of the year.

This completes the task of reducing several years that are required in the standardized approach the development of a vaccine.

As the developers of the drug, its creation was the technology of the mRNA. Testing by Pfizer is part of a larger program, which has launched in April in Germany. It is in this country is the headquarters of the company BioNTech.